MOLECULAR CELLULAR BIOLOGY, Mar. 1997, p. 1102–1109                                                                                         Vol. 17,  3
0270-7306/97/$04.0010
Copyright q 1997, American Society Microbiology



       PCF11 Encodes Protein Component Yeast Cleavage
                      Polyadenylation Factor                                 ` LE MINET, FRANC
              NADIA AMRANI, MICHE               ¸ OISE WYERS, MARIE-ELISABETH DUFOUR,
                        LAWRENCE P. AGGERBECK, FRANC   ¸ OIS LACROUTE*
                Centre Ge´ne´tique Mole´culaire, CNRS UPR 9061, University Paris VI (Pierre Marie Curie),
                                                  91198 Gif sur Yvette Cedex, France
                     Received 9 September 1996/Returned modification 11 October 1996/Accepted 3 December 1996

             Cleavage polyadenylation factor (CF  factors required vitro yeast pre-mRNA
          3*-end processing. protein components factor, encoded genes RNA14 RNA15,           identified. gene, PCF11  protein 1 CF , genetically interacts           RNA14 RNA15 presumably codes protein component CF  gene isolated
          hybrid screening designed identify proteins interacting Rna14 Rna15. PCF11           essential gene encoding protein 626 amino acids having apparent molecular mass 70 kDa.
          Thermosensitive mutations PCF11 synergistically lethal thermosensitive alleles RNA14           RNA15. Pcf11-2 thermosensitive strain shows shortening poly  tails strong decrease           steady-state level actin transcripts shift nonpermissive temperature thermosensitive
          alleles RNA14 RNA15. Extracts pcf11-1 pcf11-2 thermosensitive strains wild-type
          strain, Pcf11 neutralized specific antibodies, deficient cleavage polyadenylation. 
           fractions obtained anion-exchange chromatography extracts wild-type strain contain           Pcf11 Rna15 fractions, shown immunoblotting Pcf11-specific antibody.


   eucaryotic cells, newly synthesized mRNA mole-                     direct role endonucleolytic cleavage pri-
cules poly  tail added 39 ends early                mary transcript component yeast cleavage step maturation primary transcript. process                polyadenylation factor (CF  (27). discover new compo-
requires specific endonucleolytic cleavage precursor                     nents polyadenylation complex, used dou-
mRNA followed polymerization adenosine residues                    ble-hybrid technique (17) screen proteins interact
tail length ranging 75 residues yeast Saccha-               Rna14 Rna15 proteins. report romyces cerevisiae nearly 300 residues humans (11, 43).                 identification new gene codes component poly  tail important component determining                     CF similarly RNA14 RNA15 genes.
mRNA stability (6) efficient nuclear-cytoplasmic transport
(26). Recent work shown importance poly  tails                                                                                                        MATERIALS METHODS initiation translation cytoplasmic poly -binding
protein 1 (Pab1) (18, 21, 34); review, reference (16).                 Strains, media, genetic techniques. Yeast strains (Table 1) main-
                                                                              tained YPD (1  yeast extract, 2  peptone, 2  glucose) selective
Shortening poly  tail cytoplasmic poly  nu-                 YNB medium (0.67  yeast nitrogen base amino acids, 2  glucose)
clease probably plays important role control gene                supplemented appropriate nutritional ingredients (38). Escherichia coli
expression. process probably results decrease trans-             JM 103 endA1 thi-1 hsdR supE sbcBC strA D(lac-pro) [F9 traD36 proAB lacIq
lation stimulation degradation (8). yeast, poly -             ZDM15. BL21 [F2 ompT hsdSB (rB2 mB2) gal dcm (DE3)] grown                                                                               Luria-Bertani medium supplemented ampicillin (50 mg/ml) carbenicillin
specific RNase identified requirement poly -                 (100 mg/ml). temperature-sensitive (Ts) mutants grown 248C  
binding protein stimulated poly  nuclease activity (35, 36).                missive temperature) mid-log phase shifted 378C studies mammalian cells, poly -specific RNase par-                    nonpermissive temperature. Yeast cells transformed treatment tially purified (2), does appear require RNA-               lithium acetate polyethylene glycol (19). sporulation analysis                                                                               tetrads described previously (29).
binding protein function (3).                                            Isolation Rna14- Rna15-interacting protein GAL4 hybrid
   cleavage polyadenylation normally tightly                  Plasmids pAS2D-RNA14 pGBT-RNA15 (kind gift  Petitjean)
coupled vivo, polyadenylation uncoupled cleav-                 constructed fusing corresponding open reading frames (ORFs) age vitro use precleaved RNA substrates end                 GAL4 DNA-binding domain (GBD) encoded pAS2D (kind gift M.
                                                                              Frommont) pGBT9 (4), respectively (Table 2). pGBT9 chosen instead natural polyadenylation sites (10, 45). addition            pAS2D RNA15 fusion pAS2D-RNA15 fusion activates
endonuclease poly  polymerase, biochemistry                    reporter transcription  pAS2D pAS2 plasmid (kind gift S.
mRNA polyadenylation appears require enzy-                   Elledge) CYH2 influenza virus (Flu) epitope sequences matic activities enhance specificity rate                deleted. RNA14 amplified PCR using oligonucleotides 2592 (59-G
                                                                              CAAGATCTCCAGCTCTACGACTCCTG-39) 5145 (59-CGCGGATCCG step (12–14, 25). mechanisms proteins                     CGTTAACCTGACTTGGTGCTCTC-39) containing, respectively, BglII volved process beginning elucidated mam-                BamHI sites. PCR product cloned BamHI site pAS2D.
malian cells yeast (22, 42). yeast RNA14                Similarly, RNA15 PCR amplified using oligonucleotides 2594 (59-GCAA
RNA15 gene products, identified involve-                  GATCTTTATGAATAGGCAGAGCGGTG-39) 2596 (59-CTCAGATCTT
                                                                              CAAAATGCACCAAATTCTCC-39) containing BglII sites. PCR product
ment polyadenylation (7, 28), recently shown                  cloned BamHI site pGBT9. expression fusion proteins
                                                                              verified Western blotting.
                                                                                 select proteins interacting Rna15, strain J 693 transformed                                                                               plasmid pGBT-RNA15 FRYL library (kind gift M.
  * Corresponding author. Phone: (33) (1) 69 82 31 80. Fax: (33) (1)          Frommont) similar library constructed laboratory. libraries
69 07 55 39. E-mail: Lacroute@cgm.cnrs-gif.fr.                                consist fusions yeast genomic fragments (strain YM 955) GAL4

                                                                       1102
 VOL. 17, 1997                                                                                        CHARACTERIZATION YEAST PCF11                          1103


                                                                  TABLE 1. Yeast strains used
      Strain                                                           Genotype description                                                           Source
               W303-1B            MATa ura3-1 trp1-1 ade2-1 leu2-3,112 his3-11,15                                                                                    R. Rothstein
NA50a              MATa/MATa ura3-1/ura3-1 trp1D/trp1D ade2-1/ade2-1 leu2-3,112/leu2-3,112 his3-11,15/his3-11,15 PCF11/pcf11-D::TRP1                  study
NA52a              MATa ura3-1 trp1D ade2-1 leu2-3,112 his3-11,15 pcf11-D::TRP1/pFL38-PCF11                                                           study
NA53a              MATa ura3-1 trp1D ade2-1 leu2-3,112 his3-11,15 pcf11-D::TRP1/pFL38-PCF11                                                           study
NA54a              MATa ura3-1 trp1D ade2-1 leu2-3,112 his3-11,15 pcf11-D::TRP1/pYeF1-PCF11                                                           study
NA57a              MATa ura3-1 trp1D, ade2-1 leu2-3,112 his3-11,15 pcf11-D::TRP1/pFL36-pcf11-1                                                        study
NA64a              MATa ura3-1 trp1D ade2-1 leu2-3,112 his3-11,15 pcf11-D::TRP1/pFL36-pcf11-2                                                         study
NA65a              MATa ura3-1 trp1D ade2-1 leu2-3,112 his3-11,15 pcf11-2                                                                             study
NA66a              MATa ura3-1 tp1D ade2-1 leu2-3,112 his3-11,15 pcf11-3                                                                              study
NA67a              MATa ura3-1 trp1D ade2-1 leu2-3,112 his3-11,15 pcf11-9                                                                             study
rna15-2 Wa         MATa ura3-1 trp1-1 ade2-1 leu2-3,112 his3-11,15 rna15-2                                                                            study
rna14-1 Wa         MATa ura3-1 trp1-1 ade2-1 leu2-3,112 his3-11,15 rna14-1                                                                            study
YM 955             MATa ura3-52 ade2-101 lys2-801 leu2-3,112 tyr1-501 his3D trp1D gal4D gal80D                                                        M. Johnston
Y 190              MATa trp1-901 ade2-101 leu2-3,112 his3-11,15 URA3::UAS GAL1-lacZ gal4D gal80D LYS2::UASGAL1-HIS3 cych2r                            R. Rothstein
J 693              MATa trp1-1 ade2-1 leu2-3,112 his3-11,15 URA3::UAS GAL1-lacZ gal4D gal80D LYS2::UASGAL1-HIS3 cych2r                                R. Rothstein
FY 1679            MATa/MATa ura3-52/ura3-52 TRP1/trp1D63 LEU2/leu2D1 HIS3/his3D200                                                                   F. Winston
BMA64-2Na          MATa/MATa ura3-1/ura3-1 trp1D/trp1D ade2-1/ade2-1 leu2-3,112/leu2-3,112 his3-11,15/his3-11,15                                       Baudin
        Isogenic W303-1B.



activating domain (GAD) plasmid pACTII (kind gift S. Elledge).        step PCR amplification using oligonucleotides 6879 (59-GGTCTATTTGT
protocol followed Rna14 bait plasmid pAS2D-RNA14         AATACTCTCTTTTCATTATGGATCACGACACAGAAGTTATAGTCAAG recipient strain Y 190. His1 clones selected medium            GGGCCAAGAGGGAGGGC-39) 6881 (59-GGGCTTTTGGCTACATAT
containing 50 mM 3-aminotriazole scored lacZ expression. recov-        GTAAAATTACATATAATATAATGGACACATAAGCCTTAAATAAATA
ery pACTII clones, interaction cognate bait verified    CTACTC-39). sequences allowing TRP1 amplification underlined. Trp1 new transformation. sequence adjacent fusion site plasmid       transformants checked Southern blotting integration PCF11. determined identify corresponding yeast insert.                           Diploid strain NA50 bearing deletion PCF11 transformed pNA39
   Plasmids pACT-RNA14 pACT-RNA15 obtained switching                 (CEN URA3 PCF11) sporulated dissected obtain respective ORFs bait plasmids plasmid pACTII.                            isogenic haploid strains NA52 NA53 (Table 1), ascus.    Cloning disruption PCF11 gene. 3,024-bp genomic fragment             strains deleted genomic PCF11 complemented URA3 PCF11
containing PCF11 gene amplified PCR, starting 458 bp upstream          plasmid. initiation ATG codon ending 686 bp downstream stop codon.                Generation thermosensitive alleles. PCF11 mutagenized PCR
Genomic DNA purified strain FY 1679 (44). Amplification PCR          method Muhlrad et al. (30). PCF11 ORF amplified mutagenic
carried oligonucleotides 6880 (59-AGCTATACAGAACTTTCTCAGT                    PCR conditions, using oligonucleotides 6886 6943  . pNA46 (CEN
C-39) 6882 (59-CTAGTGTTGACGTTTTAGGAACAC-39). PCR prod-                       LEU2 PCF11) digested XhoI SphI  positions 66 1527,
uct cloned plasmid pTA (TA cloning kit; Invitrogen) generate             respectively, ORF) remove major PCF11 gene. plasmid pTA-PCF11. PCF11 insert subcloned directional cloning             gapped plasmid mutagenized PCR product cotransformed directly BamHI XbaI sites pFL38 generate URA3 PCF11                 yeast strain NA52 (pcf11-D::TRP1/CEN URA3 PCF11), Leu1 colonies
plasmid pNA39. Similarly, directional SacI-XbaI cloning pFL36        selected. endogenous URA3 PCF11 plasmid chased presence
pFL36SX  pFL36 derivative SphI XhoI sites               5-fluoro-orotic acid (5-FOA) (9), resulting colonies tested eliminated digestion blunt-end ligation) generated LEU2 PCF11             thermosensitivity.
plasmids pNA43 pNA46, respectively.                                                 DNA RNA procedures. Total yeast DNA RNA extracted    chromosomal copy PCF11 gene replaced complete               described Sherman et al. (38). DNA RNA blotting, techniques
pcf11-D::TRP1 deletion step gene disruption method (5) yeast           used described Sambrook et al. (37). ECL (enhanced chemilu-
strain BMA64 create heterozygous diploid strain NA50 (Table 1).           minescence) nucleic acid labeling detection (Amersham Corpora-
DNA fragment used transformation contains TRP1 gene flanked short         tion) used probe Southern blots. Northern blot, probes
sequences starting 28 bp upstream ending 165 bp downstream PCF11          radiolabeled [32P]dCTP 3,000 Ci/mmol (ICN). study initiation stop codons, respectively. DNA fragment generated       poly  tail, RNA 39 end labeled described previously (1). Cloned



                                                                TABLE 2. Plasmid constructions
      Plasmid                                                                         Construction

pAS2D-RNA14 ....... frame cloning PCR-amplified RNA14 ORF GBD pAS2D, using 59-end oligonuclotide 2592 39-end
                             oligonucleotide 5145, containing BglII BamHI restriction sites, respectively
pGBT-RNA15......... frame cloning PCR-amplified RNA15 ORF GBD pGBT9, using 59-end oligonucleotide 2594 39-end
                             oligonucleotide 2596 containing BglII restriction sites
pTA-PCF11 .............PCR-amplified PCF11 (3,024 bp) cloned pTA (Invitrogen), using 59-end oligonucleotide 6880 39-end oligonucleo-
                             tide 6882
pNA39..................... PCR genomic fragment containing 3,024-bp length PCF11 gene insert pTA-PCF11 cloned BamHI                              XbaI cloning sites pFL38, URA3 yeast CEN ARS-based plasmid
pNA42..................... using 59-end oligonucleotide 6990 39-end oligonucleotide 6991, containing NotI Bsu36I restriction sites, respec-
                             tively, PCF11 ORF PCR amplified cloned phase Flu epitope pYeF1, URA3 plasmid
pNA43..................... PCR genomic fragment containing 3,024-bp length PCF11 gene cloned SacI-XbaI cloning site pFL36,                              LEU2 yeast CEN ARS-based plasmid
pFL36SX..................SphI XhoI restriction sites removed polylinker pFL36, URA3 yeast CEN ARS-based plasmid
pNA46..................... PCR genomic fragment containing 3,024-bp length PCF11 gene cloned SacI-XbaI cloning site pFL36SX,                              LEU2 yeast CEN ARS-based plasmid
pNA47..................... using 59-end oligonucleotide 6886 39-end oligonucleotide 6943, containing NcoI BamHI restriction sites, respec-
                             tively, PCF11 ORF PCR amplified cloned phase polyhistidine pET-22.
 1104       AMRANI ET AL.                                                                                                                       MOL. CELL. BIOL.


PCR DNAs sequenced dideoxy method, using Sequenase kit (U.S.
Biochemical), sequence reaction products run 6  polyacryl-
amide gels.
   vitro 3*-end processing assay. excised eluted CYC1 precursor used vitro cleavage reaction previously described (27). vitro polyadenylation reaction, synthetic radiolabeled CYC1 pre-mRNA incubated wild-type (W303-1B) extract obtain precleaved precursor, phenol-chloroform-isoamyl alcohol (25:24:1) purification ethanol pre-
cipitation. yeast extracts prepared described Lin et al. (24) according modified protocol described Chen Moore (12). buffers included following protease inhibitors: 1 mM phenylmethylsulfonyl
fluoride, 0.4 mg leupeptin ml, 1.4 mg pepstatin ml. standard vitro processing reaction carried 23 358C needed 25-ml
reaction volume containing 2 ml extract. separation cleavage factors poly  polymerase activity, chromatography 1-ml Mono Q ion-
exchange column (5 50 mm; Pharmacia) performed essentially 
scribed previously (12). separation CF CF II, fractions containing
cleavage activity obtained Mono Q separations pooled, dialyzed, rechromatographed column shallower salt gradient previously described (12).
   Protein procedures antibody production. epitope-tagged Pcf11, used technique developed Cullin Minvielle-Sebastia (15). PCF11
ORF amplified PCR oligonucleotides 6990 (59-GGGGCGGCCGC
CGATCACGACACAGAAG-39) 6991 (59-GGGCCTTAGGGTTATTTTG
TGACCAATTTC-39), introduce NotI Bsu36I restriction sites 59 39 ends gene, respectively. resulting cassette cloned restriction sites pYeF1 vector, generate plasmid pNA42.              FIG. 1. Predicted amino acid sequence PCF11 product positions
cloning gives frame fusion PCF11 gene sequence encoding         Pcf11-GAD fusions. position amino acid Pcf11- Flu epitope (YPYDVPDYA), directing expression Pcf11 hybrid               GAD fusions indicated Pcf11 sequence dot detected protein tagged N terminus. Monoclonal antibody (MAb) 12CA5,              Rna14 bait asterisk isolated Rna15 bait. glu-
recognizes Flu epitope sequence, used dilution 1/50,000,          tamine stretch (aa 234 253) underlined.
proteins revealed anti-mouse antibody coupled horseradish
peroxidase (Amersham). Labeled bands visualized following processing Amersham ECL detection kit.
   Heterologous expression Pcf11 E. coli, used production antibodies, obtained using plasmid pNA47, constructed             RNA15 fusions baits, different frame fusions follows. Primers 6886 (59-CATGCCATGGATCACGACACAGAAGTTATAG                             ORF, called PCF11, isolated  times -39) 6943 (59-CCGGATCCCGTTTTGTGACCAATTTCTTTAAGTC-39), introduce NcoI BamHI restriction sites 59 39 ends         RNA14 twice RNA15). PCF11 corresponds ORF
gene, respectively, used PCR amplification generate PCF11 ORF.         YDR228C chromosome IV, encoding protein 626 aa resulting cassette cloned NcoI BamHI restriction sites        predicted molecular mass 71,853 Da. Pcf11-GAD isopropyl-b-D-thiogalactopyranoside (IPTG)-inducible His6-tagged vector           fusions isolated pACTII libraries start codons 203,
pET-22b (Novagen Corp.) orientation PCF11 ORF expressed translational fusion polyhistidine. E. coli BL21(DE3) cells    232, 271, 288, 294 PCF11 ORF (Fig. 1). corre-
transformed pNA47, protein expression induced IPTG.             sponding plasmids called pACT-PCF11(203) pACT-
Pcf11 fusion protein, contains consecutive histidine residues encoded       PCF11(294). homologous sequences known sequence vector sequence following 626 amino acids (aa) Pcf11, purified      motifs using Blastn Tblastn programs nickel-agarose column specified supplier QIAexpressionist
kit (Qiagen). total 3 mg purified Pcf11 fusion protein obtained       search databases Pcf11 sequence. middle 500 ml bacteria induced 3 h 378C IPTG.             Pcf11 stretch 20 glutamines Rabbits injected 1 mg protein times 9-week period.      hinge functional domains protein,    Purified Pcf11 protein immobilized agarose Amminolink column          functional meaning stretches remains open
using ImmunoPure Antigen/Antibody Immobilisation kit specified supplier (Pierce). milliliters crude serum applied column,    question. Pcf11-GAD fusions contained COOH
specific immunoglobulin G eluted using Pierce protocol.                    Pcf11, hinge clearly involved    antibody neutralization studies, 1 2 ml purified polyclonal anti-       interaction Pcf11 Rna14 Rna15 Pcf11 antibody incubated 2 ml wild-type extract standard            Pcf11-GAD fusions began polyglutamine stretch.
processing reaction assay. mixtures incubated 45 min 48C addition RNA precursor processing reaction. microliters         Plasmid pACT-PCF11(271), screenings, 
wild-type extract antibody treated conditions.             tained PCF11 fragment extending codons 271 452.
   Immunological techniques. Pcf11 detected immunoblot analysis            Interactions Rna14, Rna15, Pcf11 quan-
fractions obtained following anion-exchange chromatography Mono Q                titated measuring b-galactosidase activity various com-
column. Samples separated sodium dodecyl sulfate (SDS)–polyacryl-
amide gel electrotransferred nitrocellulose filter Bio-Rad transblot    binations fusion proteins (Table 3). Plasmid pACT-PCF11
apparatus (41). blot blocked 5  nonfat milk powder dissolved          (271) gives b-galactosidase activity values plasmid
Tris-buffered saline–Tween 20 buffer (37) processed immunological         pACT-PCF11(288) combinations. analysis defines detection antigens using polyclonal immune serum containing specific        region Pcf11 sufficient interaction Rna14 antibody, anti-Pcf11, anti-Rna14, anti-Rna15, dilution 1/5,000,
1/2,000 1/20,000, respectively. protein bands detected using       Rna15, extending aa 288 400.
Amersham ECL detection kit incubation blot peroxidase-                 Specificity interaction supported fact labeled antibodies rabbit immunoglobulin G dilution 1/2,000 (Amer-         interaction Pcf11 baits used
sham). microliter aliquots samples loading buffer used       false-positive detectors (data shown). determination extract protein concentrations, using Pierce bicin-
choninic acid protein assay reagent kit.                                                 PCF11 essential gene. entire coding region    Nucleotide sequence accession number. GenBank accession number             PCF11 gene replaced TRP1 gene insertion, using PCF11 YD9934_13c.                                                                  PCR strategy (5). DNA fragment, TRP1 gene                                                                                       flanked short sequences homologous 59 39 se-
                                  RESULTS                                             quences PCF11 gene, generated step PCR
                                                                                      amplification. DNA fragment used transform dip-
  Isolation PCF11 gene. screening yeast                              loid strain BMA64-2N, homozygous deletion genomic libraries hybrid assay using RNA14                               TRP1 gene (5a). independent Trp1 transformants
 VOL. 17, 1997                                                                                     CHARACTERIZATION YEAST PCF11                   1105


         TABLE 3. Interactions Rna14, Rna15,                             formed crossing pcf11-2 strain rna14-1 strain                  Pcf11 hybrid                                      rna15-2 strain transformed CEN PCF11 URA3 plas-
  GAD-expressing          GBD-expressing          Colony         b-Galactosidase
                                                                                     mid submitted tetrad analysis. tetratypes pre-
    plasmid                 plasmid               colora            activityb        senting wild-type recombinant, spores unable
                                                                                     grow 5-FOA, showing inability lose plasmid pACT-PCF11(271)           pAS2D-RNA14           Dark blue              81            necessity PCF11 wild-type gene pACT-PCF11(271)           pGBT-RNA15            Dark blue              45            survival pcf11-2 rna14-1 pcf11-2 rna15-2 double
pACT-PCF11(271)           pAS2D                 White                   1.7
pACT-PCF11(271)           pGBT9                 White                   1.6
                                                                                     mutants.
pACTII                    pAS2D-RNA14           White                   1               Effects pcf11-1 pcf11-2 mutations vivo poly-
pACTII                    pGBT-RNA15            White                   1.9          adenylation. double-hybrid synthetic le-
pACT-RNA14                pGBT-RNA15            Dark blue             310            thality establish vivo physical functional interactions
pACT-RNA15                pAS2D-RNA14           Dark blue             420            Pcf11 protein Rna14 Rna15. pACT-RNA14                pGBT9                 White                   1            decided examine Ts alleles pcf11 created
pACT-RNA15                pAS2D                 White                   1.7          defect cleavage polyadenylation mRNAs       Determined filter assay.                                                      rna14 rna15 Ts alleles (28). ability strains pos-
  b
    Quantitative b-galactosidase assays performed strain J 693 ex-         sessing pcf11-1 pcf11-2 alleles perform 39-end
pressing designed constructs. Assays described previously (23).     mRNA processing nonpermissive temperature, b-Galactosidase activity expressed Miller units. Values averages   vivo vitro, examined. investigate processing different mixtures transformants. Standard errors ,20 .
                                                                                     poly  tail vivo, total mRNAs extracted                                                                                      wild-type strain pcf11-1 pcf11-2 mutant
                                                                                     strains grown 248C grown 248C shifted analyzed Southern blotting. analysis confirmed                          378C 30 min. compared lengths  integration pcf11-D::TRP1                          poly  tails mRNAs extracted different
deleted allele PCF11 loci (data                            strains. RNAs labeled vitro 39 ends sub-
shown). Trp1 transformants subjected                             jected RNase degradation leave poly  tails
sporulation tetrad analysis, showed Mendelian                         intact. shown Fig. 2, change poly 
2:2 segregation viable nonviable spores.                          tail length wild-type mutant strains grown 248C
viable spores invariably Trp2, showing lethality                     (lanes 1, 3, 5). 378C shift, pcf11-1 mutant
spores containing pcf11-D::TRP1 deleted allele. dele-                        strain showed discrete increase poly  tail length com-
tion rescued haploid strains PCF11 sup-                          pared wild type (compare lanes 2 4), plied centromeric plasmid. result shows PCF11                         pcf11-2 mutant strain displayed significant reduction essential gene.                                                                poly  tail length (compare lane 2 lane 6).
   Isolation pcf11 thermosensitive alleles. Mutagenic PCR                            actin mRNA pcf11-1 pcf11-2
conditions used generate thermosensitive mutations                           mutant strains shifted 378C quantitated Northern PCF11 gene. Yeast strain NA52 (pcf11-D::TRP1/CEN                              blotting. shown Fig. 3, mutant strains displayed URA3 PCF11) cotransformed PCR-mutagenized                                   rapid reduction steady-state level ACT1 mRNA
PCF11 ORF gapped plasmid pNA46 (CEN LEU2                                     shift 378C (lanes 4 6).
PCF11)  Materials Methods). Leu1 colonies                                  pcf11-1 pcf11-2 mutations alter 3*-end process-
selected. endogenous CEN URA3 PCF11 plasmid                                  ing CYC1 pre-mRNA vitro. Extracts wild- counterselected replica plating Leu1 transformants                       type strain mutant pcf11-1 pcf11-2 strains, grown 5-FOA medium, 5-FOA plates replica plated                            permissive temperature, tested vitro 39-end YNB plates incubated 378C identify thermosensitive                          processing 23 358C, using synthetic radiolabeled CYC1
colonies. independent colonies showed inhibition                           precursor mRNA (Fig. 4). analyzed cleavage 
growth 378C; mutant alleles carried                        action conditions allowed cleavage recessive, named pcf11-1 pcf11-11.                         labeled CYC1 precursor (Fig. 4A). wild-type extract,
pcf11-2, pcf11-3, pcf11-9 alleles integrated                         CYC1 precursor cleaved, generating 59 39 frag-
chromosomal PCF11 locus create thermosensitive strains                            ments (185 116 nucleotides, respectively), NA65, NA66, NA67, respectively. achieved                             efficiency 23 358C (Fig. 4A, lanes 2 6). 238C, transforming strain NA52 (pcf11-D::TRP1/CEN URA3 PCF11)                              pcf11-1 pcf11-2 extracts produce times BamHI-EcoRV fragments bearing pcf11 mutations                               cleavage product wild-type extract (compare lanes 2 selecting strains able lose URA3 PCF11 plas-                         4). 358C, little (pcf11-1) (pcf11-2) cleavage
mid 5-FOA 248C.  Leu1 Trp1 cells                               product detected (lanes 7 8). polyadenylation
corresponded background undigested LEU2 pcf11 plas-                          reaction performed precleaved CYC1 precursor  mids, Leu2 Trp2 cells corresponded integration                        Materials Methods) (Fig. 4B). wild-type extract, 59 Ts alleles original locus.                                             CYC1 precursor fragment polyadenylated 70
   Synthetic lethality pcf11 mutation rna14                        adenosine residues 23 358C (Fig. 4B, lanes 2 rna15 mutations. confirm apparent vivo association                         6). 238C, pcf11-1 pcf11-2 extracts, observed Pcf11 Rna14 Rna15, strains containing                            formation short poly  tail precleaved CYC1
pcf11-2, pcf11-3, pcf11-9 allele crossed                     (Fig. 4B, lanes 3 4). 358C, poly  tail detected
rna14-1 rna15-2 strain. Tetrads analyzed                            mutant extract (Fig. 4B, lanes 7 8).  vitro,
corresponding diploids, tetratype contained                       pcf11 mutants defective 39-end cleavage poly- wild-type recombinant, spore nonviable                         adenylation.
permissive temperature, showing synthetic lethality                             Neutralization Pcf11 wild-type extract. Treatment different pcf11 Ts alleles rna14 rna15 Ts allele.                     wild-type extract purified anti-Pcf11 antibody completely tetratypes obtained cross. obtain                     abolished activities CYC1 cleavage polyadenylation confirmation synthetic lethality, diploids                        (Fig. 5, lanes 3, 4, 7, 8). control inhibition
 1106       AMRANI ET AL.                                                                                                                     MOL. CELL. BIOL.


                                                                                        Copurification Pcf11 protein CF complex.
                                                                                     test Pcf11 protein component CF                                                                                       constructed epitope-tagged Pcf11 protein order mon-
                                                                                     itor copurification components poly-
                                                                                     adenylation complex. PCF11 ORF generated PCR 
                                                                                     plification cloned pYeF1 vector  Materials
                                                                                     Methods). fusion PCF11 Flu epitope                                                                                      plasmid pNA42 shown functional complementa-
                                                                                     tion pcf11-D::TRP1 deletion transformation                                                                                      PCF11/pcf11-D::TRP1 diploid strain NA50 (Table 1). Trans-
                                                                                     formants plated selective medium, sporulation
                                                                                     induced obtain, haploids, strain NA54;                                                                                      pcf11-D::TRP1 strain carries plasmid pNA42, produces
                                                                                     epitope-tagged Pcf11 protein.
                                                                                        cell extracts prepared NA54 used                                                                                      starting material fractionation studies. crude
                                                                                     extract applied Mono Q anion-exchange column,                                                                                      proteins eluted increasing salt gradient (12).
                                                                                     Fractions analyzed SDS-polyacrylamide gel elec-
                                                                                     trophoresis, transferred nitrocellulose membranes,                                                                                      probed MAb 12CA5  recognizes Flu epitope)
                                                                                     anti-Rna14 anti-Rna15 antibodies. shown Fig. 6,
                                                                                     epitope-tagged Pcf11 protein coeluted Rna14                                                                                      Rna15. Fraction 12 shows intense signal Pcf11, Rna14,
                                                                                     Rna15. Pcf11 reproducibly eluted 445 mM KCl,
                                                                                     corresponds ionic strength cleavage
                                                                                     activity factors CF CF II elute (12).
                                                                                        purification separating CF CF II used
                                                                                     localize Pcf11 complexes. Cleavage
                                                                                     activity-containing fractions obtained Mono Q sepa-
                                                                                     rations pooled, dialyzed, reloaded Mono Q column
                                                                                     (5 50 mm), eluted shallow salt gradient 
                                                                                     scribed Chen Moore (12). low efficiency detec-
                                                                                     tion epitope-tagged Pcf11 MAb 12CA5 did allow
                                                                                     detection Pcf11. undertook production                                                                                      polyclonal antibody Pcf11. PCF11 ORF intro-
                                                                                     duced T7 expression vector, large quantities                                                                                      histidine-tagged protein obtained. material pu-
                                                                                     rified nickel column injected rabbits antibody
                                                                                     production. seen Fig. 7, Pcf11 specifically
                                                                                     recognized antiserum used 1/5,000 dilution.                                                                                      apparent molecular mass nearly 70 kDa, ob-
                                                                                     served assays using MAb 12CA5 epitope-tagged
                                                                                     Pcf11 (Fig. 6). Western blotting analysis purified CF                                                                                      CF II complexes Mono Q eluates anti-Pcf11
                                                                                     antibody showed presence Pcf11 fractions
   FIG. 2. Lengths poly  tails wild-type strain pcf11-1 pcf11-2 mutant strains shift 378C. Cells grown 248C      contained Rna15 (Fig. 7) Rna14 (data shown).
shifted 378C 30 min. microgram total RNA 39-end labeled RNA ligase [59-32P]pCp digested RNase RNase T1 yield intact labeled poly . electrophoresis 15  polyacryl-
amide–8 M urea gel, poly  tails visualized autoradiography. Mark-
ers indicate sizes  nucleotides) poly  tails.



 nonspecific effect resulting addition antibodies, used anti-yeast Pab protein antibodies purified using conditions. observed cleavage inhibition equivalent amounts purified
polyclonal antibodies used (data shown). preim-
mune antibodies used control completely degraded precursor. Pcf11 immunoneutraliza-
tion wild-type extract causes exactly deficiency                      FIG. 3. ACT1 mRNA left heat inactivation Pcf11.                                                                                      mRNA levels determined Northern blot analysis; 10 mg total RNA
CYC1 processing seen pcf11 mutant extracts.                          resuspended RNA sample buffer, samples fractionated sult provides additional evidence Pcf11 necessary                        1  agarose gel 13 morpholine propanesulfonic acid buffer. RNA blot
cleavage polyadenylation pre-mRNA.                                            hybridized radioactive ACT1 ORF fragment.
 VOL. 17, 1997                                                                                        CHARACTERIZATION YEAST PCF11                              1107




   FIG. 4. Temperature dependence cleavage polyadenylation wild-type pcf11 mutant extracts vitro.   cleavage reaction, synthetic
radiolabeled CYC1 pre-mRNAs incubated extracts wild-type (lanes 2 6), pcf11-1 (lanes 3 7), pcf11-2 (lanes 4 8) strains 60 min 23 358C indicated. (B) polyadenylation reaction, CYC1 mRNAs precleaved wild-type extract assayed standard reaction conditions 60
min cell extracts wild-type (lanes 2 6), pcf11-1 (lanes 3 7), pcf11-2 (lanes 4 8) strains 23 358C indicated. products analyzed 6  polyacrylamide–7 M urea electrophoresis gel.


 data demonstrate clearly Pcf11 copurifies CF  participates cleavage polyadenylation steps.

                              DISCUSSION
   study, identified, genetic bio-
chemical criteria, PCF11 new yeast gene product involved polyadenylation mRNAs. genetic iden-
tification relies lines evidence.  double-
hybrid  Pcf11 interacts Rna14 Rna15, proteins polyadenylation machinery (27,
28). Second, thermosensitive pcf11 alleles present synthetic
lethality thermosensitive alleles RNA14 RNA15. genetic observations suggest Pcf11, like Rna14 Rna15, functionally involved mRNA 39-end processing.
Biochemical analysis pcf11 mutants confirms genetic
results, reveals defects similar observed rna14-1 rna15-2 Ts mutants (27, 28). restrictive
growth conditions,  vivo, shortening mRNA
poly  tails strong decrease steady-state level ACT1 mRNA. vitro, extracts pcf11 Ts mu-
tant Pcf11 neutralized wild-type extracts deficient cleavage polyadenylation CYC1
transcript, suggesting like Rna14 Rna15, Pcf11 component CF  data strongly support assump-
tion, Pcf11 copurifies Rna15 nondena-
turing conditions allow purification functional
CF complex (12). results, taken  strongly
suggest Pcf11  previously unknown component CF yeast.                                                                          FIG. 5. Inhibition 39-end cleavage polyadenylation activity wild-
                                                                                     type extract immunoneutralization anti-Pcf11 antibody. Cleavage (lanes
   Analysis interactions proteins                        1 4) polyadenylation (lanes 5 8) tested separately. inactivation hybrid allows definition region Pcf11                     processing activity obtained 1 ml (lanes 3 7) 2 ml (lanes 4 sufficient interaction Rna14 Rna15.                          8) purified anti-Pcf11 antibody.
 1108       AMRANI ET AL.                                                                                                                        MOL. CELL. BIOL.


                                                                                    pare isolated yeast (22), tempting                                                                                     look homolog PCF11 genes                                                                                     related polyadenylation higher organisms.                                                                                      significant homology Pcf11 prod-
                                                                                    ucts known genes cDNAs database
                                                                                    sequences searched using Tblastn program.                                                                                     left following possibilities:   Pcf11 fungal
                                                                                    specific component, (ii) homolog Pcf11                                                                                     data banks evolutionary conservation sequence
                                                                                    low recognized, (iii) homolog Pcf11
                                                                                    exists sequenced higher organisms.
                                                                                                             ACKNOWLEDGMENTS
   FIG. 6. Western blot analysis N-terminal epitope-tagged Pcf11,
Rna14, Rna15 proteins obtained anion-exchange chromatography                                                                                        thank M. Frommont providing FRYL library plas-
Mono Q column. microliters fraction loaded SDS–10             mid pAS2D  Petitjean gift plasmid pGBT-RNA15 polyacrylamide gel, Pcf11, Rna14, Rna15 revealed Western            critical reading manuscript. thank S. Elledge plasmids
blotting. Detection 1/20,000 dilution anti-Rna15 antibody,     pACTII pAS2  Baudin strain BMA64-2N. thank D.
1/50,000 dilution MAb 12CA5 tagged Pcf11, 1/2,000 dilution           Menay synthesis oligonucleotides.
anti-Rna14 antibody. Protein molecular masses indicated right.              work supported EEC project TAPIR  hybrid
                                                                                    analysis proteins involved RNA metabolism), Association                                                                                     la Recherche sur le Cancer, Centre National la Recherche
                                                                                    Scientifique.
113-aa polypeptide sequence corresponds Pcf11
sequence aa 288 400, located downstream                                                               REFERENCES
                                                                                     1. Amrani, N., M. E. Dufour, N. Bonneaud, F. Lacroute. 1996. Mutations
glutamine stretch. hypotheses advanced ac-                                STS1, suppress defect 39 messenger RNA processing rna15-2
count positive interaction Pcf11 Rna14                              mutations. Mol. Gen. Genet. 252:552–562.
Rna15:   direct interaction Pcf11                          2. Åstro¨m, J.,  Åstro¨m,  Virtanen. 1991. vitro deadenylation Rna14 Rna15; (ii) Pcf11 interacts directly                            mammalian mRNA HeLa cell 39 exonuclease. EMBO J. 10:3067–3071.
                                                                                     3. Åstro¨m, J.,  Åstro¨m,  Virtanen. 1992. Properties HeLa cell proteins, positive signal obtained                            39exonuclease specific degrading poly  tails mammalian mRNA. resulting tight association Rna14                            J. Biol. Chem. 267:18154–18159. Rna15, suggested (27) confirmed                         4. Bartel, P. L., C. T. Chien, R. Sternglanz, S. Fields. 1993. Using hybrid assays (Table 3).                                                            hybrid detect protein-protein interaction. Oxford University
                                                                                        Press, Oxford, England.
   function Pcf11? vivo phenotypes                          5. Baudin, , O. Ozier-Kalogeropoulos,  Denouel, F. Lacroute, C. Cul-
thermosensitive pcf11, rna14, rna15 mutants (28)                           lin. 1993. simple efficient method direct gene deletion Saccha-
similar mutants                            romyces cerevisiae. Nucleic Acids Res. 21:3329–3330.
bearing Ts mutations PAP1 gene, encoding poly                           5a.Baudin-Baillieu, , E. Guillemet, C. Cullin, F. Lacroute. Construction
                                                                                        yeast strain deleted TRP1 promoter coding region polymerase (33), FIP1 gene (32), encoding compo-                            enhances efficiency PCR-disruption method. Yeast, press.
nent polyadenylation factor. Interestingly, true                  6. Bernstein, P., S. W. Peltz, J. Ross. 1989. poly -poly -binding pcf11 mutant alleles, vivo, pcf11-1,                           protein complex major determinant mRNA stability vitro. Mol.
pcf11-2 (Fig. 2), shows small increase length                           Cell. Biol. 9:659–670.
                                                                                     7. Bloch, J. C., F. Perrin, F. Lacroute. 1978. Yeast temperature-sensitive
poly  tails. Despite clearer differentiation func-                        mutants impaired processing poly -containing RNAs. Mol. Gen.
tions PCF11, RNA14, RNA15 (27), PAP1 (31), FIP1 (32)                             Genet. 165:123–127. use vitro  vitro vivo                  8. Boeck, R., S. Tarun, M. Rieger, J.  Deardorff, S. Mu  ¨ller-Auer,  B.
phenotype permits identification precise biochemical                           Sachs. 1996. yeast Pan2 protein required poly -binding protein-
reaction linked PCF11.                                                               stimulated poly -nuclease activity. J. Biol. Chem. 271:432–438.
                                                                                     9. Boeke, J. D., F. Lacroute, G. R. Fink. 1984. positive selection    higher eucaryotes, 77- 64-kDa proteins homologous                             mutants lacking orotidine-59 phosphate decarboxylase activity yeast: 5- Rna14 Rna15, respectively (39), identified                          fluoroorotic acid resistance. Mol. Gen. Genet. 197:345–346.
components CstF (20, 40). activities                        10. Butler, J. S., T. Platt. 1988. RNA processing generates mature 39 end
components different fractions polyadenylation                            yeast CYC1 messenger RNA vitro. Science 242:1270–1274.
                                                                                    11. Butler, J. S., P. P. Sadhale, T. Platt. 1990. RNA processing vitro
complexes isolated higher eucaryotes difficult com-                         produces mature 39 ends variety Saccharomyces cerevisiae mRNAs.
                                                                                        Mol. Cell. Biol. 10:2599–2605.
                                                                                    12. Chen, J., C. Moore. 1992. Separation factors required cleavage
                                                                                        polyadenylation yeast pre-mRNA. Mol. Cell. Biol. 12:3470–3481.
                                                                                    13. Christofori, G., W. Keller. 1988. 39 cleavage polyadenylation                                                                                         mRNA precursors vitro requires poly  polymerase, cleavage factor
                                                                                        snRNP. Cell 54:875–889.
                                                                                    14. Christofori, G., W. Keller. 1989. Poly  polymerase purified                                                                                         HeLa cell nuclear extract required cleavage polyadenylation
                                                                                        pre-mRNA vitro. Mol. Cell. Biol. 9:193–203.
                                                                                    15. Cullin, C., L. Minvielle-Sebastia. 1994. Multipurpose vectors designed
                                                                                        fast generation N- C-terminal epitope-tagged proteins. Yeast
                                                                                        10:105–112.
                                                                                    16. Curtis, D., R. Lehmann, P. D. Zamore. 1995. Translational regulation                                                                                         development. Cell 81:171–178.
   FIG. 7. Copurification Pcf11 Rna15. Fractions anion-exchange         17. Fields, S., R. Sternglanz. 1994. hybrid  assay chromatography Mono Q column contained cleavage activity                protein-protein interactions. Trends Genet. 10:286–292.
pooled, dialyzed, reseparated Mono Q column shallow salt            18. Gallie, D. R. 1991. cap poly  tail function synergistically gradient. Fractions electophoresed SDS–10  polyacrylamide gel.               regulate mRNA translational efficiency. Genes Dev. 5:2108–2116. blot probed anti-Pcf11 antibody dilution 1/5,000      19. Gietz, R. D., R. H. Schiestl,  R. Willems, R.  Woods. 1995. Studies
anti-Rna15 antibody dilution 1/20,000. positions protein molecular       transformation intact yeast cells LiAc/SS-DNA/PEG pro-
weight markers indicated right.                                              cedure. Yeast 11:355–360.
 VOL. 17, 1997                                                                                        CHARACTERIZATION YEAST PCF11                              1109


20. Gilmartin, G. M., J. R. Nevins. 1991. Molecular analysis poly        33. Proweller, , S. Butler. 1994. Efficient translation poly  deficient
    site-processing factors determine recognition efficiency cleav-       mRNA Saccharomyces cerevisiae. Genes Dev. 8:2629–2640.
    age pre-mRNA. Mol. Cell. Biol. 11:2432–2438.                               34. Sachs,  1990. role poly  translation stability mRNA.
21. Jackson, R. J., N. Standart. 1990. Does poly  tail 39 untrans-          Curr. Opin. Cell. Biol. 2:1092–1098.
    lated region control mRNA translation? Cell 62:15–24.                             35. Sachs,  1993. Messenger RNA degradation eucaryotes. Cell 74:413–421.
22. Keller, W. 1995. end messenger RNA 39 processing. Cell 81:829–          36. Sachs,  B., J.  Deardorff. 1992. Translation initiation requires     832.                                                                                  PAB-dependent poly  ribonuclease yeast. Cell 70:961–973.
23. Kuras, L., D. Thomas. 1995. Functional analysis Met4, yeast tran-        37. Sambrook, J., E. F. Fritsch, T. Maniatis. 1989. Molecular cloning:     scriptional activator responsive S-adenosylmethionine. Mol. Cell. Biol.            laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold
    15:208–216.                                                                           Spring Harbor, N.Y.
24. Lin, R. J.,  J. Newman, S. C. Cheng, J. Abelson. 1985. Yeast mRNA           38. Sherman, F., G. R. Fink, J. B. Hicks. 1986. Laboratory course manual
    splicing vitro. J. Biol. Chem. 260:14780–14792.                                    methods yeast genetics. Cold Spring Harbor Laboratory, Cold Spring
25. Manley, J. L., N. J. Proudfoot. 1994. RNA 39 ends: formation                                                                                           Harbor, N.Y.
    function-meeting review. Genes Dev. 8:259–264.
                                                                                      39. Takagaki, Y., J. L. Manley. 1994. polyadenylation factor subunit 26. Maquat, L. E. 1991. Nuclear mRNA export. Curr. Opin. Cell Biol. 3:1004–
                                                                                          human homologue Drosophila suppressor forked protein. Nature
    1012.
27. Minvielle-Sebastia, L., P. J. Preker, W. Keller. 1994. RNA14                  372:471–474.
    RNA15 proteins components yeast pre-mRNA 39-end processing                40. Takagaki, Y., J. M. Manley, C. C. McDonald, J. Wilusz, T. Shenk. 1990.
    factor. Science 266:1702–1705.                                                        multisubunit factor, CstF, required polyadenylation mammalian
28. Minvielle-Sebastia, L., B. Winsor, N. Bonneaud, F. Lacroute. 1991.                pre-mRNAs. Genes Dev. 4:2112–2120.
    Mutations yeast RNA14 RNA15 genes result abnormal                41. Towbin, H., T. Staehelin, J. Gordon. 1979. Electrophoretic transfer     mRNA decay rate: sequence analysis reveals RNA-binding domain               proteins polyacrylamide gels nitrocellulose sheets: procedure     RNA15 protein. Mol. Cell. Biol. 11:3075–3087.                                         applications. Proc. Natl. Acad. Sci. USA 76:4350–4354.
29. Mortimer, R. K., D. C. Hawthorne. 1966. Genetic mapping Saccha-            42. Wahle, E., W. Keller. 1996. biochemistry polyadenylation. Trends
    romyces cerevisiae. Genetics 53:165–173.                                              Biochem. Sci. 21:247–250.
30. Muhlrad, D., R. Hunter, R. Parker. 1992. rapid method localized         43. Wickens, M. 1990. messengers got tail: addition poly      mutagenesis yeast genes. Yeas